Drugs / 740YP
last change Jul 2017 re-read 3 minutes ago

740YP

Developed for
female infertility · primary ovarian failure
Investigated by
Fertility Laboratories Of Colorado · National Foundation for Fertility Research

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02496598 Jul 2015 → Jul 2017 female infertility, primary ovarian failure National Foundation for Fertility Research Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 740YP “Ovarian cortical pieces will be treated in vitro with a PTEN activator (bpV(hopic)) and a PI3K inhibitor (740YP) in vitro to activate primordial ovarian follicles, prior to...” NCT02496598 ↗
Action Inhibit “PI3K inhibitor” NCT02496598 ↗